Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study AR Mato, NN Shah, W Jurczak, CY Cheah, JM Pagel, JA Woyach, ... The Lancet 397 (10277), 892-901, 2021 | 352 | 2021 |
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology IW Deveson, B Gong, K Lai, JS LoCoco, TA Richmond, J Schageman, ... Nature biotechnology 39 (9), 1115-1128, 2021 | 148 | 2021 |
Cell type specific chromosome territory organization in the interphase nucleus of normal and cancer cells NV Marella, S Bhattacharya, L Mukherjee, J Xu, R Berezney Journal of cellular physiology 221 (1), 130-138, 2009 | 79 | 2009 |
Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines NV Marella, KS Malyavantham, J Wang, S Matsui, P Liang, R Berezney Cancer research 69 (14), 5946-5953, 2009 | 62 | 2009 |
Chromosomal rearrangements during human epidermal keratinocyte differentiation NV Marella, B Seifert, P Nagarajan, S Sinha, R Berezney Journal of cellular physiology 221 (1), 139-146, 2009 | 31 | 2009 |
Alterations in replication timing of cancer‐related genes in malignant human breast cancer cells A Fritz, S Sinha, N Marella, R Berezney Journal of cellular biochemistry 114 (5), 1074-1083, 2013 | 30 | 2013 |
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions B Gong, D Li, R Kusko, N Novoradovskaya, Y Zhang, S Wang, ... Genome biology 22, 1-23, 2021 | 21 | 2021 |
Analytical accuracy of RET fusion detection by break-apart fluorescence in situ hybridization JA Baker, AN Sireci, N Marella, HK Cannon, TJ Marquart, TR Holzer, ... Archives of Pathology & Laboratory Medicine 146 (3), 351-359, 2022 | 6 | 2022 |
Genomic Evolution and Resistance during Pirtobrutinib Therapy in Covalent BTK-Inhibitor (cBTKi) Pre-Treated Chronic Lymphocytic Leukemia Patients: Updated Analysis from the … JR Brown, SP Desikan, B Nguyen, H Won, SI Tantawy, S McNeely, ... Blood 142, 326, 2023 | 4 | 2023 |
S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II … JR Brown, SP Desikan, B Nguyen, H Won, S Tantawy, SC Mcneely, ... HemaSphere 7, e6233246, 2023 | 2 | 2023 |
Organization of the amplified type I interferon gene cluster and associated chromosome regions in the interphase nucleus of human osteosarcoma cells MJ Zeitz, NV Marella, KS Malyavantham, S Goetze, J Bode, I Raska, ... Chromosome research 17, 305-319, 2009 | 2 | 2009 |
Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63 NV Marella, MJ Zeitz, KS Malyavantham, A Pliss, S Matsui, S Goetze, ... Chromosome research 16, 1177-1192, 2008 | 2 | 2008 |
Fixed-duration pirtobrutinib combined with venetoclax±rituximab in relapsed/refractory chronic lymphocytic leukemia: updated results, including MRD data, from the BRUIN phase … LE Roeker, JA Woyach, CY Cheah, CC Coombs, NN Shah, WG Wierda, ... Blood 142, 3269, 2023 | 1 | 2023 |
GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY K Patel, JR Brown, SP Desikan, B Nguyen, H Won, SI Tantawy, ... Hematological Oncology 41, 185-187, 2023 | 1 | 2023 |
Pirtobrutinib in Richter Transformation: Updated Efficacy and Safety Results with 18-Month Median Survival Follow-up from the Phase 1/2 BRUIN Study WG Wierda, NN Shah, CY Cheah, D Lewis, MS Hoffmann, CC Coombs, ... Blood 142, 1737, 2023 | | 2023 |
Evaluation of RET Fusion Identification by the Idylla GeneFusion Assay M Lacy, N Sireci, N Marella, T Marquart JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S79-S79, 2022 | | 2022 |
Appendix B. Published in Journal of Cellular Biochemistry AJ Fritz, S Sinha, NV Marella, R Berezney ELUCIDATING CHROMOSOME TERRITORY ORGANIZATION DURING THE CELL CYCLE AND IN …, 2014 | | 2014 |
Spatial genome organization: Interrelationships of chromosome territories and genes to nuclear architecture NV Marella State University of New York at Buffalo, 2009 | | 2009 |
THE BEREZNEY LAB IN SPOTLIGHT NR Marella, K Malyavantham B iologue, 5, 2007 | | 2007 |
LOXO-305 in Relapsed or Refractory B-cell Malignancies AR Mato, NN Shah, W Jurczak, CY Cheah, JM Pagel, JA Woyach, ... | | |